glutathione synthetase deficiency peripheral smear Diagnosis from the Blood Impaired Glutathione Synthesis in Neurodegeneration
Description
doi: 10.1016/j.ajhg.2011.11.022

Santello et al., 2019

Thus, further studies must be conducted to address these challenges

Patients often spend years in treatment that does not address the actual problem

For obesity treatment, higher maintenance doses within the labeled range consistently produce the greatest, most long-term weight loss in randomized trials: Semaglutide 2.4 mg led to about 15 percent average weight loss at 68 weeks in STEP trials
